Testosterone Therapy: An Assessment of the Clinical Consequences of Changes in Hematocrit and Blood Flow Characteristics.
König CS, Balabani S, Hackett GI, Strange RC, Ramachandran S.
König CS, et al. Among authors: balabani s.
Sex Med Rev. 2019 Oct;7(4):650-660. doi: 10.1016/j.sxmr.2019.01.003. Epub 2019 Mar 26.
Sex Med Rev. 2019.
PMID: 30926458
Review.
At present, there appears no scientific basis for using a hematocrit of 0.54 to modify TTh; other values may be more appropriate in particular patient groups. Konig CS, Balabani S, Hackett GI, et al. Testosterone Therapy: An Assessment of the Clinical Consequences o …
At present, there appears no scientific basis for using a hematocrit of 0.54 to modify TTh; other values may be more appropriate in particul …